Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
34.19
-0.41 (-1.18%)
At close: Aug 28, 2026, 4:00 PM EDT
33.91
-0.28 (-0.82%)
After-hours: Aug 28, 2026, 7:58 PM EDT
Vera Therapeutics Employees
Vera Therapeutics had 361 employees as of June 30, 2026. The number of employees increased by 169 or 88.02% compared to the same quarter last year.
Employees
361
Change
169
Growth
88.02%
Revenue / Employee
n/a
Profits / Employee
-$1,113,283
Market Cap
2.46B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 361 | 169 | 88.02% |
| Mar 31, 2026 | 339 | 187 | 123.03% |
| Dec 31, 2025 | 249 | 137 | 122.32% |
| Sep 30, 2025 | 224 | 142 | 173.17% |
| Jun 30, 2025 | 192 | 120 | 166.67% |
| Mar 31, 2025 | 152 | 97 | 176.36% |
| Dec 31, 2024 | 112 | 61 | 119.61% |
| Sep 30, 2024 | 82 | 33 | 67.35% |
| Jun 30, 2024 | 72 | 23 | 46.94% |
| Mar 31, 2024 | 55 | 9 | 19.57% |
| Dec 31, 2023 | 51 | 5 | 10.87% |
| Sep 30, 2023 | 49 | 8 | 19.51% |
| Jun 30, 2023 | 49 | 20 | 68.97% |
| Mar 31, 2023 | 46 | 28 | 155.56% |
| Dec 31, 2022 | 46 | 29 | 170.59% |
| Sep 30, 2022 | 41 | 26 | 173.33% |
| Jun 30, 2022 | 29 | 16 | 123.08% |
| Mar 31, 2022 | 18 | 6 | 50.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Nuvation Bio | 305 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
| Pharvaris | 148 |
| Kodiak Sciences | 141 |
| Mesoblast | 108 |
VERA News
- 5 days ago - 3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts - TipRanks
- 12 days ago - Vera Therapeutics price target lowered to $90 from $125 at H.C. Wainwright - TheFly
- 18 days ago - Vera Therapeutics price target raised to $84 from $78 at Raymond James - TheFly
- 18 days ago - Vera Therapeutics price target lowered to $34 from $43 at Wedbush - TheFly
- 18 days ago - Vera Therapeutics price target lowered to $66 from $70 at BofA - TheFly
- 19 days ago - Vera Therapeutics reports Q3 EPS ($1.52), consensus ($1.59) - TheFly
- 19 days ago - Vera Therapeutics Earnings release: Q2 2026 - Filings
- 19 days ago - Vera Therapeutics Quarterly report: Q2 2026 - Filings